This could be indirect, relating to reductions of cytokines such as TGF-β, IL-6, or the immune suppressor and MDSC-inducer cytokine, IL-10 [49–51], all of which are over-expressed in CLL [32]. This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.